Financhill
Back

Vor Biopharma Stock Predictions

Vor Biopharma Stock Forecast

  • Is Vor Biopharma Stock Undervalued?
    The current Vor Biopharma [VOR] share price is $2.12. The Score for VOR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • VOR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Vor Biopharma Stock Go Up Next Year?

Data Unavailable

Vor Biopharma Stock Rating

Data Unavailable

Vor Biopharma Stock Price History

Is VOR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VOR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vorbio.com

52-Week Data

52-Week High:
3.29
52-Week Low:
0.13

Prediction Charts

Market Cap:
264.9M
Price in USD:
2.12
Volume:
12.5M
Beta:
2.07

Technical Analysis

SMA50:
0.73
SMA100:
0.77
SMA200:
0.89
52-Wk Change:
109.9%

Stock Predictions

  • Is Vor Biopharma stock public?
    Yes, Vor Biopharma is a publicly traded company.
  • What is the Vor Biopharma stock quote today?
    The Vor Biopharma stock price is 2.12 USD today.
  • How to buy Vor Biopharma stock online?
    You can buy Vor Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 1.00 0.89 1.26 0.71
Jun-27 0.94 1.06 1.23 0.91
Jun-30 1.12 1.62 1.74 1.11
Jul-1 1.54 1.43 2.04 1.38
Jul-2 1.54 1.45 1.80 1.40
Jul-3 1.58 1.91 1.97 1.54
Jul-7 2.00 2.67 3.20 2.00
Jul-8 3.00 2.40 3.29 2.36
Jul-9 2.51 2.54 3.02 2.40
Jul-10 2.60 2.31 2.64 2.25
Jul-11 2.30 2.50 2.84 2.30
Jul-14 2.50 2.39 2.66 2.25
Jul-15 2.42 2.25 2.54 2.23
Jul-16 2.31 2.12 2.37 1.92

Vor Biopharma Earnings

Data Unavailable

Vor Biopharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.78 per share, and an increase next year of $0.31 per share.

* Vor Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.